GoHealth (GOCO) Stock Price, News & Analysis

Company Overview

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $5.51 to $5.72
• 50-Day Range: $5.39 to $6.42
• 52-Week Range: $5.01 to $21.00
• Volume: 36,275 shs
• Average Volume: 59,881 shs
• Market Capitalization: $130.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.00
• Consensus Rating: Moderate Buy

GoHealth Stock Analysis - MarketRank™

GoHealth scored higher than 49% of companies evaluated by MarketBeat, and ranked 609th out of 938 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

GoHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

GoHealth has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for GoHealth are expected to grow in the coming year, from ($5.50) to ($3.91) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of GoHealth is -1.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of GoHealth is -1.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

GoHealth has a P/B Ratio of 0.31. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.60% of the float of GoHealth has been sold short.

Short Interest Ratio / Days to Cover

GoHealth has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in GoHealth has recently decreased by 2.35%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

GoHealth does not currently pay a dividend.

Dividend Growth

GoHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.60% of the float of GoHealth has been sold short.

Short Interest Ratio / Days to Cover

GoHealth has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in GoHealth has recently decreased by 2.35%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for GoHealth this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, GoHealth insiders have not sold or bought any company stock.

Percentage Held by Insiders

33.98% of the stock of GoHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 24.21% of the stock of GoHealth is held by institutions.

GOCO Stock Analysis - Frequently Asked Questions

How have GOCO shares performed this year?

GoHealth's stock was trading at $13.39 at the beginning of the year. Since then, GOCO stock has decreased by 58.8% and is now trading at $5.51.

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NASDAQ:GOCO) posted its earnings results on Thursday, August, 7th. The company reported ($1.23) EPS for the quarter, beating analysts' consensus estimates of ($2.60) by $1.37. The company had revenue of $94.05 million for the quarter, compared to the consensus estimate of $119.76 million. GoHealth had a negative net margin of 3.21% and a negative trailing twelve-month return on equity of 8.74%.
Read the conference call transcript.

When did GoHealth IPO?

GoHealth (GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

Who are GoHealth's major shareholders?

GoHealth's top institutional investors include Corient Private Wealth LLC (0.53%), Geode Capital Management LLC (0.50%), Marshall Wace LLP (0.21%) and Bridgeway Capital Management LLC (0.11%). Insiders that own company stock include Cayman Gp Ltd Ccp III, Blizzard Holdings C LP Cb, Vijay Kotte and Jason Schulz.
View institutional ownership trends.

How do I buy shares of GoHealth?

Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of GoHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that GoHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Invesco QQQ (QQQ), Tesla (TSLA), Netflix (NFLX) and Intel (INTC).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 8/19/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: INS - LIFE
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:GOCO
• CIK: 1808220
• Web: www.gohealth.com
• Phone: 312-386-8200
• Fax: N/A
• Employees: 2,261
• Year Founded: N/A

Price Target and Rating

• Average Price Target for GoHealth: $18.00
• High Price Target: $18.00
• Low Price Target: $18.00
• Potential Upside/Downside: +226.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.93 million
• Net Margins: -3.21%
• Pretax Margin: -6.00%
• Return on Equity: -8.74%
• Return on Assets: -2.26%

Debt

• Debt-to-Equity Ratio: 2.64
• Current Ratio: 1.56
• Quick Ratio: 1.56

Sales & Book Value

• Annual Sales: $822.44 million
• Price / Sales: 0.16
• Cash Flow: $2.28 per share
• Price / Cash Flow: 2.42
• Book Value: $17.62 per share
• Price / Book: 0.31

Miscellaneous

• Outstanding Shares: 23,738,000
• Free Float: 15,672,000
• Market Cap: $130.80 million
• Optionable: Not Optionable
• Beta: 1.49